Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
-
Park Jin-young Denies Cult Allegations Against Firstfruits Group
-
Writer Realizes She Is Lesbian After Child Comes Out as Transgender
-
MotorTrend's Top Electric Vehicle Picks for 2026
-
GTA 6 Advertising Strategy and Disc Version Controversy
-
St Francis School Leads €60,000 EU Project to Transform Early Childhood Education
-
IT’S TIME TO SHINE: ELEKTROS Thanks Its Shareholders and Looks Toward a Brighter Future in Critical Minerals and EV Technology
-
ELEKTROS Invites Shareholders to Shine Bright as the Holiday Season Nears, with Focus on Lithium, Critical Minerals and EV Innovation
-
As the Most Wonderful Time of the Year Approaches, ELEKTROS Celebrates Its Shareholders and Looks Ahead to a Bright Future
-
How to Find Joy in a Simpler, More Intentional Lifestyle
-
1986 Yugo GT with 121 Miles Listed for Sale on Bring a Trailer
-
Ukrainian MP Oleksiy Kucherenko Accidentally Exposes Himself During Live TV Interview
-
Malta Stuns Sweden with Late Penalty Comeback in Rugby Europe Trophy
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually, on Thursday, May 29, 2025.
Company Webcast
The webcast presentation will take place at 11:00 a.m. ET on Thursday, May 29, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2025/ or directly at https://app.webinar.net/Zyr70D402Aj. The webcast will also be available for replay following the event.
1x1 Meetings
Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at [email protected] or register for the event at https://lythampartners.com/spring2025invreg/.
About Modular Medical
Modular Medical, Inc. (NASDAQ:MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
[email protected]
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
K.Hill--AT
